ABNORMAL T WAVE INVERSIONS AND EXTREME QT PROLONGATION
Keywords:
Abnormal T wave inversions, long QT, ventricular arrhythmias, pacingAbstract
Introduction: Cardiovascular diseases are the cause of sudden cardiac arrest. One of the leading causes of death is the occurrence of ventricular arrhythmias. Prompt evaluation, diagnosis and management of ventricular arrhythmias are life-saving for these patients.
Case report: We present the case of a 70-year-old female patient with neurological sensorimotor polyneuropathy with quadriparesis and verified chronic renal failure (CRF) gr. IV admitted at the University Clinic for Nephrology for acute renal failure. After hemodialysis treatment, she developed arrhythmogenic disability such as episodes of ventricular fibrillation (VF) and ventricular tachycardia (VT). The onset of VT/VF required pharmacologic and shock therapy treatment. Electrocardiogram (ECG) at presentation upon admission to the cardiology clinic was with abnormal T wave and QT inversions. We did not find any electrolytic disturbances or echocardiographic abnormalities in search for ischemia segment wall changes. Coronary angiography showed no significant lesions of the coronary arteries. Our strategy for treating this long QT interval was temporary pacing with high doses of b-blockers. According to the good response to the therapy, the patient got permanent pacing therapy (AAIàDDD mode) and till this day she is still safe from occurrence of ventricular arrhythmias.
Conclusion: Prolongation of ventricular repolarization in patients with long QT interval must be registered as a predictor of occurrence of ventricular arrhythmias.
References
Myerburg RJ, Kessler KM, Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 1993; 119: 1187-97.
Myerburg RJ, Interian AJr, Mitrani RM, Kessler KM, Castellanos A. Frequency of sudden cardiac death and profiles of risk. Am J Cardiol 1997; 80: 10F-19F.
Gorgels AP, Gijsbers C, de Vreede-Swagemakers J, Lousberg A, Wellens HJ. Out-of-hospital cardiac arrest – the relevance of heart failure. The Maastricht Circulatory Arrest Registry. Eur Heart J 2003; 24: 1204-9.
Vink AS, Neumann B, Lieve KVV, Sinner MF, Hofman N, El Kadi S, et al. Determination and interpretation of the QTinterval. Circulation 2018; 138: 2345-58. doi: 10.1161/ CIRCULATIONAHA.118.033943 pmid: http://www. ncbi.nlm.nih.gov/pubmed/30571576.
Adler A, Novelli V, Amin AS, Abiusi E, Care M, Nannenberg EA, et al. An international, multicentered, evidence-based reappraisal of genes reported to cause congenital long QT syndrome. Circulation 2020; 141: 418-28. doi: 10.1161/ CIRCULATIONAHA.119.043132 pmid:http://www.ncbi.nlm.nih.gov/pubmed/31983240.
Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 2006; 47: 362-7.
Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. Timing of new black box warnings and withdrawals for prescription medications. JAMA 2002; 287: 2215-20.
Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004; 350: 1013-22.
Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003; 289: 2120-7.
Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003; 89: 1363-72.
Bazett HC. The time relations of the blood-pressure changes after excision of the adrenal glands, with some observations on blood volume changes. J Physiol 1920; 53: 320-39.
Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 2015; 132(22): e326-9.
Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association. Circulation 2006; 114(10): e385-484.
Koponen M, Marjamaa A, Hiippala A, Happonen JM, Havulinna AS, Salomaa V, et al. Follow-up of 316 molecularly defined pediatric long-QT syndrome patients: clinical course, treatments, and side effects. Circ Arrhythm Electrophysiol 2015; 8(4): 815-23.
Ferri FF. Long QT syndrome. In: Ferri's Clinical Advisor 2020. Elsevier 2020.
Wilde AAM, Ackerman MJ. Beta-Blockers in the treatment of congenital long QT syndrome: is one beta-blocker superior to another? J Am Coll Cardiol 2014; 64: 1359-61. doi:10.1016/j.jacc.2014.06.1192 pmid:http://www.ncbi.nlm.nih.gov/pubmed/25257638.
Früh A, Siem G, Holmström H, Haugaa KH. The Jervell and Lange-Nielsen syndrome; atrial pacing combined with ß-blocker therapy, a favorable approach in young high-risk patients with long QT syndrome? Heart Rhythm 2016; 13: 2186-92. doi: 10.1016/j.hrthm.2016.07.020 pmid:http://www.ncbi.nlm. nih.gov/pubmed /27451284.
Downloads
Published
Versions
- 2022-11-30 (2)
- 2022-06-15 (1)
